Search Orphan Drug Designations and Approvals
-
Generic Name: | hydroxyurea |
---|---|
Date Designated: | 04/15/2005 |
Orphan Designation: | Treatment of pediatric patients with sickle cell anemia. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
UPM Pharmaceuticals, Inc. 6200 Seaforth Street Baltimore, Maryland 21224 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-